Conference Coverage

Site of morphea lesions predicts risk of extracutaneous manifestations


 

REPORTING FROM SPD 2018


Among all patients, the researchers found that left-extremity and extensor-extremity lesions had a stronger association with musculoskeletal involvement (odds ratios of 1.26 and 1.94, respectively). “The reasons for this are unclear,” Dr. Chiu said. “We didn’t assess handedness in our study, but that perhaps could explain it; 90% of the general population is right-hand dominant, so perhaps there’s some sort of protective effect if you’re using an extremity more. Joint contractures showed the greatest discrepancy between left and right extremity. So perhaps if you’re using that one side more, you’re less likely to have a joint contracture.”

When the researchers limited the analysis to head lesions, they observed no significant difference in the lesions between the left and right head (OR, 0.72), but anterior head lesions had a stronger association with neurologic signs or symptoms, compared with posterior head lesions (OR, 2.56), as did superior head lesions, compared with inferior head lesions (OR, 2.23). The association between head lesion location and ophthalmologic involvement was not significant.

“The odds of extracutaneous manifestations vary by site of morphea lesions, with higher odds seen on the left extremity, extensor extremity, the anterior head, and the superior head,” Dr. Chiu concluded. “Further research can be done to perhaps help us decide whether this necessitates difference in management or screening.”

The project was funded by the Pediatric Dermatology Research Alliance and the SPD. Dr. Chiu reported having no relevant financial disclosures.

dbrunk@mdedge.com

Pages

Recommended Reading

New JIA guidelines emphasize treating to target
MDedge Rheumatology
Psoriasis duration reflects cardiovascular event risk
MDedge Rheumatology
MDedge Daily News: How to handle opioid constipation
MDedge Rheumatology
FDA approves subcutaneous tocilizumab for polyarticular JIA
MDedge Rheumatology
EULAR pediatric sessions to highlight big data, personalized medicine
MDedge Rheumatology
EULAR scientific program highlights spectrum of translational research
MDedge Rheumatology
In JIA, etanercept associated with lower uveitis risk compared with methotrexate
MDedge Rheumatology
Limited anakinra course often enough for systemic JIA if used first
MDedge Rheumatology
Uric acid tied to pediatric diabetic kidney disease
MDedge Rheumatology
How to identify DVT faster in pediatric osteomyelitis
MDedge Rheumatology